Clinical Trial Update: Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3) [Phase 3]

View source ↗

Summary

A Phase 3 trial update (ADVANCE-3) reports results from an investigational drug intended to prevent thrombosis after hip replacement. The study is completed and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Pulmonary Embolism

Drugs mentioned

• Investigational drug (ADVANCE-3)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Deep Vein Thrombosis, Pulmonary Embolism | Phase 3 | Status: COMPLETED | Results posted: 2014-05-14